Scholarly article on N-(2-methyl-4-((phenylsulfonyl)amino)phenyl)benzenesulfonamide 200348-81-8 from Journal of the American Chemical Society p. 4601,4605

DOI: 10.1021/ja01166a074

Source and publish data:

Journal of the American Chemical Society p. 4601,4605 (1950)

Update date:2022-08-03

Topics:

Authors:

Adams Adams

Nagarkatti

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01166a074

Full text of DOI:10.1021/ja01166a074

Products guided by the article

Product name:N-(2-methyl-4-((phenylsulfonyl)amino)phenyl)benzenesulfonamide

Cas No:200348-81-8

R&D Labs maybe for 200348-81-8

RongCheng K&S Chemical Co.,Ltd

Contact:0631-7336369

Address:rongcheng ,shandong province china
Shanghai Hongbang Medical Technology CO.,. Ltd

Contact:13671516988 /18917636693

Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
SJZ Chenghui Chemical Co., Ltd.

Contact:86-311-87713916

Address:no.368 youyi north avenue
Taimai Sanluck Pharmaceutical Co.,Ltd

Contact:86-592-7662921

Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Beijing Cooperate Pharmaceutical Co.,Ltd

website:http://www.cooperate-pharm.com/

Contact:86-01060279497

Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base

Relevant to this article

A new modification of 1,1′-Bis(diphenylphosphine oxide)ferrocene at 173 K

Doi:10.1107/S0108270197011207
(1997)
Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine

Doi:10.1016/S0006-2952(97)00403-6
(1997)
Synthesis of acetamides via oxidative C–C bond cleavage of ketones catalyzed by Cu-immobilized magnetic nanoparticles

Doi:10.1002/aoc.5855
(2020)
Total synthesis of the novel, immunosuppressive agent (-)-pateamine A from Mycale sp. employing a β-lactam-based macrocyclization

Doi:10.1021/ja973549f
(1998)
Enantioselective synthesis of 4-substituted 2-pyrrolidinones by site- selective C-H insertion of α-methoxycarbonyl-α-diazoacetanilides catalyzed by dirhodium(II) tetrakis[N-phthaloyl-(S)-tert-leucinate]

Doi:10.1016/S0040-4039(97)10493-2
(1998)
In vitrostudies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics

Doi:10.1039/d0cc08156f
(2021)

Article Doi

DOI: 10.1021/ja01166a074